Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Deutsche Bank AG (DB) vs Invesco Ltd. (IVZ) Price & Performance

Deutsche Bank AGTrade
Invesco Ltd.Trade

Price performance (Past 24H)

Key statistics

Deutsche Bank AG vs Invesco Ltd. — how do they compare? Deutsche Bank AG trades at $38.21 (market cap $71.96B), while Invesco Ltd. trades at $31.16 (market cap $13.85B). The key difference: Deutsche Bank AG is far larger — about 5.2× Invesco Ltd.'s market cap, and Deutsche Bank AG pays the higher dividend (3.04%). Which is the better fit depends on your goals.

DBIVZ
Market Cap
$71.96B$13.85B
Sector
FinancialsFinancials
52-Week High
$40.33$32.01
52-Week Low
$28.37$20.67
Dividend Yield
3.04%2.74%
Enterprise Value
$24.01B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Deutsche Bank AG

In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.

Read more on DB

About Invesco Ltd.

Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).

Read more on IVZ